Trisalus Life Sciences Inc (TLSI) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Trisalus Life Sciences Inc   (NASDAQ: TLSI)


Trisalus Life Sciences Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Trisalus Life Sciences Inc's ROI in the second quarter of 2026?
Trisalus Life Sciences Inc recorded a cumulative net loss of $-47 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -116.93%.

Within the Healthcare sector 633 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3405 to 4130.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 99.4 % 108.27 % 85.37 % 79.29 % 43.51 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 51 59 24 26 32
Return On Investment (TTM) -116.93 % -130.41 % -235.09 % -263.54 % -155.46 %
TLSI's Overall Ranking # 4130 # 3405 # 3266 # 3996 # 3662
Seq. Investment Change TTM 13.72 % 43.07 % 11.44 % 9.97 % 18.78 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -47 -46 -58 -58 -31




Return On Investment TLSI's Ranking
Within: No.
Industry # 148
Sector # 634
Overall # 4130

Return On Investment Statistics
High Average Low
4.08 %
-204.57 %
-908.12 %
(Jun 30 2022)   (Mar 31 2024)







Financial Statements
Trisalus Life Sciences Inc's II. Quarter Investments $ 51 Millions TLSI's Balance sheet
Trisalus Life Sciences Inc's II. Quarter Income $ -9 Millions Quarterly TLSI's Income Statement
TLSI's Income by Division See TLSI's Income by Division


TLSI Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 24 14 11 -2 240
Y / Y Investment Growth 73.41 % 24.51 % - - -1.22 %
Net Income in Millions -58 -30 -62 6 5
Y / Y Net Income Growth - - - 16.19 % -
Annual Return On Investment -242.29 % -218.62 % -561.87 % - 1.98 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TLSI's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TLSI's Competitors
Subscribers only: Roi for Trisalus Life Sciences Inc's Suppliers
Subscribers only: Return On Investment for TLSI's Customers

Other Ratios
TLSI's Roa TLSI's Inventory Turnover Ratio TLSI's Growth Rates TLSI's Dividend Statistics
TLSI's Profitability Ratios TLSI's Asset Turnover Ratio TLSI's Dividend Growth
TLSI's Roe TLSI's Valuation Ratios TLSI's Financial Strength Ratios TLSI's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-26T07:39:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.